الفهرسة نشطة
للباحثين للناشرين تسجيل الدخول إنشاء حساب
الرئيسية المؤلفون Mohamed A. Kharfan-Dabaja
MK

Mohamed A. Kharfan-Dabaja

h-7 H-Index
152 Citations
15 Papers

Published Papers

15 indexed
1
The Risk and Prognosis of COVID-19 Infection in Cancer Patients
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2020.07.005
80 citations 398
2
Lisocabtagene Maraleucel in Relapsed or Refractory Diffuse Large B Cell Lymphoma
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2021.09.004
12 citations 394
3
CAR-T cell Therapies for B-cell Lymphoid Malignancies
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1026
9 citations 390
4
C-reactive protein and ferritin levels and length of intensive care unit stay in patients with B-cell lymphomas treated with axicabtagene ciloleucel ☆
Hematology/Oncology and Stem Cell Therapy Q3 2021 10.1016/j.hemonc.2020.09.004
8 citations 390
5
Management of CAR T-cell Related Toxicities
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1029
8 citations 390
6
Intraocular involvement of Mantle cell lymphoma
Hematology/Oncology and Stem Cell Therapy Q3 2021 10.1016/j.hemonc.2019.03.002
7 citations 388
7
Predictors and Management of Relapse to Axicabtagene Ciloleucel in Patients with Aggressive B-cell Lymphoma ☆
Hematology/Oncology and Stem Cell Therapy Q3 2023 10.1016/j.hemonc.2021.09.001
7 citations 391
8
Efficacy of Allogeneic Hematopoietic Cell Transplantation in Patients With Chronic Phase CML Resistant or Intolerant to Tyrosine Kinase Inhibitors
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2021.02.003
6 citations 393
9
Post-Autologous Hematopoietic Cell Transplant Care in the “Home Sweet Home” Setting: A Treatment Paradigm Shift
Hematology/Oncology and Stem Cell Therapy Q3 2023 10.56875/2589-0646.1088
6 citations 392
10
Understanding the Etiology of Pancytopenias in the CAR T-Cell Therapy Setting
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1047
4 citations 391
11
Emerging Role of Autologous CD19 CAR T-Cell Therapies in the Second-Line Setting for Large B-cell Lymphoma
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1025
3 citations 391
12
Relapse of Hodgkin lymphoma after autologous hematopoietic cell transplantation
Hematology/Oncology and Stem Cell Therapy Q3 2021 10.1016/j.hemonc.2020.05.011
1 citations 391
13
Allogeneic hematopoietic cell transplantation as the standard of care for blastic plasmacytoid dendritic cell neoplasm in first complete remission
Hematology/Oncology and Stem Cell Therapy Q3 2025 10.4103/hemoncstem.hemoncstem-d-25-00023
1 citations 385
14
Effect of Somatic Variants Post Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Hematology/Oncology and Stem Cell Therapy Q3 2025 10.4103/hemoncstem.hemoncstem-d-25-00029
0 citations 393
15
Impact of mental health on outcomes of patients with relapsed and/or refractory diffuse large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy
Hematology/Oncology and Stem Cell Therapy Q3 2026 10.4103/hemoncstem.hemoncstem-d-26-00018
0 citations 389

Publication Activity

Journals Published In

Hematology/Oncology and Stem Cell Therapy
🇸🇦 Q3 AMS 72